A method and pharmaceutical composition for treating Spirochete phylum borne illnesses administered to a patient in need of such treatment at least one of tinidazole concentration between 10 to 10,000 mg dissolving bacterial biofilm or other nitroimidazole class drugs in combination with minocycline concentration of approximately 5 to 600 mg killing a bacterial infection co-administered with one of the five Vitamin Ds.
